Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial

NCT05639959 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Rhinosinusitis

Interventions

DRUG: Mometasone Nasal 50 Mcg/Inh Nasal Spray
DEVICE: Nasal spray

Sponsor

Saffron Pharma